Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8205 EUR | -0.24% | -1.38% | -20.42% |
Sales 2024 * | 266M 289M 394M | Sales 2025 * | 304M 329M 449M | Capitalization | 553M 599M 817M |
---|---|---|---|---|---|
Net income 2024 * | -10M -10.84M -14.78M | Net income 2025 * | 4M 4.34M 5.91M | EV / Sales 2024 * | 1.74 x |
Net cash position 2024 * | 87.65M 95.03M 130M | Net cash position 2025 * | 109M 118M 161M | EV / Sales 2025 * | 1.46 x |
P/E ratio 2024 * |
-51.3
x | P/E ratio 2025 * |
-205
x | Employees | 382 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.66% |
Latest transcript on Pharming Group N.V.
1 day | -0.24% | ||
1 week | -1.38% | ||
1 month | -6.39% | ||
3 months | -20.95% | ||
6 months | -24.03% | ||
Current year | -20.42% |
Managers | Title | Age | Since |
---|---|---|---|
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Jeroen Wakkerman
DFI | Director of Finance/CFO | 55 | 20-11-15 |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pykett
BRD | Director/Board Member | 60 | 20-12-10 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-05-18 |
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 2 M€ | -.--% | ||
0.05% | 7 M€ | -.--% | - | |
0.02% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.8205 | -0.24% | 21,900,890 |
24-05-30 | 0.8225 | +1.54% | 2,283,787 |
24-05-29 | 0.81 | -4.09% | 3,773,563 |
24-05-28 | 0.8445 | +2.18% | 4,595,581 |
24-05-27 | 0.8265 | -0.66% | 5,121,589 |
Real-time Euronext Amsterdam, May 31, 2024 at 11:37 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.42% | 599M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- PHARM Stock